Grell, P.; Borilova, S.; Fabian, P.; Selingerova, I.; Novak, D.; Muller, P.; Kiss, I.; Vyzula, R.
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer. Cancers 2023, 15, 1901.
https://doi.org/10.3390/cancers15061901
AMA Style
Grell P, Borilova S, Fabian P, Selingerova I, Novak D, Muller P, Kiss I, Vyzula R.
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer. Cancers. 2023; 15(6):1901.
https://doi.org/10.3390/cancers15061901
Chicago/Turabian Style
Grell, Peter, Simona Borilova, Pavel Fabian, Iveta Selingerova, David Novak, Petr Muller, Igor Kiss, and Rostislav Vyzula.
2023. "FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer" Cancers 15, no. 6: 1901.
https://doi.org/10.3390/cancers15061901
APA Style
Grell, P., Borilova, S., Fabian, P., Selingerova, I., Novak, D., Muller, P., Kiss, I., & Vyzula, R.
(2023). FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer. Cancers, 15(6), 1901.
https://doi.org/10.3390/cancers15061901
